$GTBP GT Biopharma Ripping! 🚀 Up 47% 🔹 Huge move as biotech momentum comes flying back into this microcap 📈 🔹 GT Biopharma is developing NK cell engager the

$GTBP GT Biopharma Ripping! 🚀 Up 47% 🔹 Huge move as biotech momentum comes flying back into this microcap 📈 🔹 GT Biopharma is developing NK cell engager therapies targeting difficult cancers 🧬 🔹 Lead program GTB-3650 is in a Phase 1 trial for CD33+ leukemias, including AML and high-risk MDS 🔥…